These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 36250045)

  • 1. Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules.
    Lv L; Ruan G; Ping Y; Cheng Y; Tian Y; Xiao Z; Zhao X; Chen D; Wei Y
    Front Cell Infect Microbiol; 2022; 12():1025889. PubMed ID: 36250045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline gut microbial profiles are associated with the efficacy of
    Hong G; Li Y; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Scand J Gastroenterol; 2023 Apr; 58(4):339-348. PubMed ID: 36281578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live
    Srivastava S; Basak U; Naghibi M; Vijayakumar V; Parihar R; Patel J; Jadon PS; Pandit A; Dargad RR; Khanna S; Kumar S; Day R
    Gut Microbes; 2024; 16(1):2338322. PubMed ID: 38630015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
    Körner E; Lorentz A
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36882216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of probiotics on symptoms of irritable bowel syndrome].
    Kim YG; Moon JT; Lee KM; Chon NR; Park H
    Korean J Gastroenterol; 2006 Jun; 47(6):413-9. PubMed ID: 16809947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
    Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
    Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study].
    Yakovenko EP; Strokova TV; Ivanov AN; Iakovenko AV; Gioeva IZ; Aldiyarova MA
    Ter Arkh; 2022 Feb; 94(2):180-187. PubMed ID: 36286741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Sun YY; Li M; Li YY; Li LX; Zhai WZ; Wang P; Yang XX; Gu X; Song LJ; Li Z; Zuo XL; Li YQ
    Sci Rep; 2018 Feb; 8(1):2964. PubMed ID: 29445178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of
    Chen YM; Li Y; Wang X; Wang ZL; Hou JJ; Su S; Zhong WL; Xu X; Zhang J; Wang BM; Wang YM
    World J Gastroenterol; 2022 Feb; 28(5):532-546. PubMed ID: 35316963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study.
    Madsen AMA; Halkjær SI; Christensen AH; Günther S; Browne PD; Kallemose T; Hansen LH; Petersen AM
    Scand J Gastroenterol; 2021 Jul; 56(7):761-769. PubMed ID: 34000958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Geng LL; Huang H; Xuan YC; Wan JW; Yu XJ; Nie XF; Hu XW
    Zhongguo Zhen Jiu; 2023 Sep; 43(9):1028-32. PubMed ID: 37697878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Multistrain Probiotic on Leaky Gut in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study.
    Ait Abdellah S; Gal C; Laterza L; Velenza V; Settanni CR; Napoli M; Schiavoni E; Mora V; Petito V; Gasbarrini A
    Dig Dis; 2023; 41(3):489-499. PubMed ID: 36007493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Live Combined
    Pi X; Teng W; Fei D; Zhao G; Liu W
    Front Cell Infect Microbiol; 2022; 12():821662. PubMed ID: 35223547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules.
    Guo Q; Lin H; Chen P; Tan S; Wen Z; Lin L; He J; Wen J; Lu S
    Bioengineered; 2021 Dec; 12(2):11885-11897. PubMed ID: 34923901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea].
    Drozdov VN; Shikh EV; Astapovskii AA; Khalaidzheva KN; Solovieva SA; Dorogun OB
    Vopr Pitan; 2023; 92(4):92-103. PubMed ID: 37801459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
    BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.